The clinical protection provided by the combined administration of ERYSENG® PARVO and UNISTRAIN® PRRS against the Porcine Reproductive Respiratory Syndrome (PRRS) in gilts was assessed in this study. Reproductive performance after a heterologous challenge was the main efficacy parameter.